4.6 Review

New perspectives on PPAR, VDR and FXRα as new actors in testicular pathophysiology

Journal

MOLECULAR ASPECTS OF MEDICINE
Volume 78, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.mam.2020.100886

Keywords

-

Funding

  1. Inserm, CNRS, Universite Clermont Auvergne
  2. French government IDEX-ISITE initiative [16-IDEX-0001]

Ask authors/readers for more resources

The study highlights the emerging roles of members of the nuclear receptor superfamily in male fertility disorders and discusses their potential as biomarkers or therapeutic targets for the management of fertility disorders.
The incidence of reproductive disorders is constantly increasing and affects 15% of couples, with male's abnormalities diagnosed in almost half of the cases. The male gonads exert two major functions of the testis with the productions of gametes (exocrine function) and of sexual hormones (endocrine function). In the last decades, next to steroid receptors such as estrogen and androgen receptors, the involvement of other members of the nuclear receptor superfamily have been described such as Steroidogenic factor-1 (SF-1), Nerve growth factor IB (NGFIB), Liver-X-Receptora (LXR alpha) and Dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX-1). The purpose of this review is to highlight the emerging roles of some members of the nuclear receptor superfamily among which the vitamin-D Receptor (VDR), Peroxisome Proliferator-Activated Receptor (PPAR), Farnesoid-X-Receptor-alpha (FXR alpha). We discuss how these receptors could participate to explain male fertility disorders; and their potential to be use as biomarkers or therapeutic targets for management of fertility disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available